Radiopharmaceuticals, used in the field of nuclear medicine, are radioactive substances which are given to patients for treatment of cancer as well as for some types of imaging. Radiopharmaceuticals include technetium-99, cobalt-57, and chromium-51.
Categories
Diagnostic RadiopharmaceuticalsTherapeutic Radiopharmaceuticals |
Recommended Resources
Comparative Cytotoxicity of Ionic and Non-Ionic Radiocontrast Agents
This article, published in a journal about nephrology dialysis transplantation, goes over the facts surrounding the cases of acute renal failure in patients who use various radiocontrast agents, what their existing conditions are which ma promote such failure, and citations.
http://ndt.oxfordjournals.org/content/14/2/342.abstract
Public Health Statement for Cobalt
The Agency for Toxic Substances and Disease Registry has published this item which discusses cobalt, what it is, and what happens to it when it enters the environment. It also discusses the effect of cobalt on the body and where one may get more information on the topic.
http://www.atsdr.cdc.gov/toxprofiles/phs33.html
Contains an overview of the history of Technetium-99m since its beginnings in 1958 and how it came to be the most common pharmacologic agents used in diagnosis.
http://www.bnl.gov/bnlweb/history/tc-99m.asp
